Enveric Biosciences Inc. Gains 74.7%

Thu, Feb 29, 2024 at 07:10 PM

Enveric Biosciences Inc. (ENVB:NASDAQ) shot up at $1.45, representing a gain of 74.7%. On Thu, Feb 29, 2024, ENVB:NASDAQ hit a New 2-Week High of $1.45. The stock appeared on our News Catalysts scanner on Thu, Feb 29, 2024 at 08:12 AM in the 'MISCELLANEOUS' category. From Thu, Feb 15, 2024, the stock recorded 33.33% Up Days and 30.00% Green Days

The stock spiked on Thu, Feb 29, 2024 at $2.92 with a volume of 176M+.

About Enveric Biosciences Inc. (ENVB:NASDAQ)

Enveric Biosciences Inc is a patient-centric biotechnology company focused on developing new-generation, naturally occurring chemical compounds, such as cannabinoids to improve the lives of those who...

Top 10 Gainers:

Societal CDMO Inc. (SCTL:NASDAQ), 132.61%
Sizzle Acquisition Corp. (SZZL:NASDAQ), 125.23%
Enveric Biosciences Inc. (ENVB:NASDAQ), 74.7%
Sidus Space Inc. (SIDU:NASDAQ), 61.22%
Ideanomics, Inc. (IDEX:NASDAQ), 54.9%
LAVA Therapeutics N.V. (LVTX:NASDAQ), 54.17%
Eastman Kodak Company (KODK:NYSE), 52.57%
OneMedNet Corp. (ONMD:NASDAQ), 45.82%
Renalytix AI plc (RNLX:NASDAQ), 40.98%
Laser Photonics Corporation (LASE:NASDAQ), 39.42%